2017
DOI: 10.5543/tkda.2017.57606
|View full text |Cite
|
Sign up to set email alerts
|

Simultaneous Total Occlusion of Two Coronary Arteries Associated with Use of Drospirenon - Ethinyl Estradiol (Oral Contraceptive)

Abstract: Although the use of oral contraceptives is associated with an increased risk of venous thromboembolic disease, the risk of myocardial infarction (MI) is unclear. A new, third-generation contraceptive agent, drospirenone-ethinyl estradiol, which contains less estrogen and a new progestogen, drospirenone, in a different combination, has been considered more reliable in terms of risk of MI. However, there have been some cases of MI associated with the use of drospirenone-ethinyl estradiol, despite the protective … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 1 publication
0
2
0
Order By: Relevance
“…The literature contains 3 case reports on Yasmin and MI but lacks information on the simultaneous occlusion of more than 3 epicardial coronary arteries. The simultaneous total occlusion of 2 coronary arteries (the left anterior descending and circumflex coronary arteries) was reported by Atmaca et al 7 In the reports of Orti 8 and Kocabay, 9 the culprit lesion was confined to 1 coronary artery. Currently, no guideline-based therapy exists for patients who develop MI during OCS use.…”
Section: Discussionmentioning
confidence: 78%
See 1 more Smart Citation
“…The literature contains 3 case reports on Yasmin and MI but lacks information on the simultaneous occlusion of more than 3 epicardial coronary arteries. The simultaneous total occlusion of 2 coronary arteries (the left anterior descending and circumflex coronary arteries) was reported by Atmaca et al 7 In the reports of Orti 8 and Kocabay, 9 the culprit lesion was confined to 1 coronary artery. Currently, no guideline-based therapy exists for patients who develop MI during OCS use.…”
Section: Discussionmentioning
confidence: 78%
“…In another case, the diagnosis of the patient was acute anterolateral MI, treated with stenting for both coronary arteries and a tirofiban infusion. 7 Kocabay et al 9 used an intracoronary tissue plasminogen activator injection for the occluded left anterior descending coronary artery. They also used heparin with the tirofiban infusion for 48 hours.…”
Section: Discussionmentioning
confidence: 99%